lobbying_activities: 2528070

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2528070	5573588b-a97c-4083-b626-b864dd503452	Q3	SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES	401105162	SWISHER INTERNATIONAL, INC., F/K/A SI GROUP CLIENT SERVICES	2020	third_quarter	TOB	Outreach and monitoring related to the tobacco industry. Outreach and monitoring related to federal COVID-19 relief and stimulus legislation. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065)	HOUSE OF REPRESENTATIVES,SENATE		300000	0	0	2020-10-20T12:36:19.743000-04:00